Medico Intercontinental Ltd
Medico Intercontinental Ltd (MIL) last reported results for the quarter ended Jun 2026, with sales of ₹20.71 crore and net profit of ₹-4.05 crore. The stock last traded at ₹26, a market capitalisation of ₹26 crore. Over the past 52 weeks the stock has ranged between ₹20.6 and ₹43. Figures are as of 6 Oct 2026 and are not real time.
Medico Intercontinental Ltd share price and key metrics
- Current price
- ₹26
- Market cap
- ₹26 cr
- Book value
- ₹46.9
- ROE
- -6.96%
- ROCE
- -1.98%
- Dividend yield
- 0.00%
- 52w high / low
- 43.0/20.6
Metrics as of 6 Oct 2026. Not real time.
Track Medico Intercontinental Ltd
Cruxal reads every Medico Intercontinental Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Medico Intercontinental Ltd growth and returns
- 10 Years
- %
- 5 Years
- 4%
- 3 Years
- 3%
- TTM
- -14%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -221%
- 10 Years
- %
- 5 Years
- -10%
- 3 Years
- -33%
- 1 Year
- -31%
- 10 Years
- %
- 5 Years
- 7%
- 3 Years
- 4%
- Last Year
- -7%
Medico Intercontinental Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹20.71 cr, down 3.0% from ₹21.35 cr a year earlier. Net profit was ₹-4.05 cr, down 62.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 36.45 | 18.43 | 21.16 | 21.35 | 20.4 | 19.85 | 22.49 | 20.71 |
| Expenses | 33.74 | 16.52 | 19.22 | 20.67 | 21.28 | 18.26 | 20.88 | 21.4 |
| Operating profit | 2.71 | 1.91 | 1.94 | 0.68 | -0.88 | 1.59 | 1.61 | -0.69 |
| OPM % | 7.43% | 10.36% | 9.17% | 3.19% | -4.31% | 8.01% | 7.16% | -3.33% |
| Other income | 0.1 | 0.13 | 0.11 | 0.29 | 0.55 | 0.34 | 0.11 | 0.13 |
| Interest | 0.28 | 0.24 | 0.3 | 2.36 | 2.06 | 1.9 | 1.85 | 1.91 |
| Depreciation | 0.2 | 0.23 | 0.28 | 0.62 | 1.95 | 1.43 | 1.43 | 1.21 |
| Profit before tax | 2.33 | 1.57 | 1.47 | -2.01 | -4.34 | -1.4 | -1.56 | -3.68 |
| Tax % | 29.61% | 27.39% | 22.45% | 23.88% | 4.61% | 20.00% | 51.28% | 10.33% |
| Net profit | 1.63 | 1.17 | 1.17 | -2.49 | -4.51 | -1.66 | -2.33 | -4.05 |
| EPS (₹) | 1.63 | 1.17 | 1.17 | -0.68 | -1.65 | -0.22 | -0.65 | -1.45 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Medico Intercontinental Ltd annual results
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 10 | 82 | 70 | 74 | 76 | 71 | 95 | 84 | 83 |
| Operating profit | -0 | 1 | 4 | 5 | 5 | 5 | 6 | 8 | 3 | 2 |
| OPM % | — | 7% | 5% | 7% | 7% | 7% | 8% | 9% | 3.6% | 1.9% |
| Net profit | 0 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | -11 | -13 |
| EPS (₹) | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.95 | 5.06 | -3.20 | -3.97 |
TTM is the trailing twelve months to the most recent quarter.
Medico Intercontinental Ltd balance sheet
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3 | 3 | 3 | 3 | 3 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 1 | 3 | 6 | 9 | 31 | 35 | 40 | 37 |
| Borrowings | 0 | 0 | 14 | 9 | 9 | 5 | 5 | 17 | 67 |
| Other liabilities | 1 | 5 | 16 | 12 | 11 | 13 | 6 | 10 | 3 |
| Total liabilities | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 77 | 117 |
| Fixed assets | 0 | 0 | 2 | 2 | 2 | 3 | 4 | 9 | 51 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2 |
| Other assets | 4 | 9 | 34 | 28 | 30 | 56 | 53 | 65 | 64 |
| Total assets | 4 | 9 | 36 | 31 | 32 | 59 | 56 | 77 | 117 |
As reported by the company. Total assets equal total liabilities by construction.
Medico Intercontinental Ltd cash flow
| ₹ crore | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | 1 | -14 | 6 | 4 | -10 | 6 | -6 | 17 |
| Cash from investing | 0 | 0 | 0 | -1 | -1 | -5 | -9 | -5 | 2 |
| Cash from financing | 0 | 0 | 13 | -5 | -1 | 20 | -0 | 10 | -16 |
| Net cash flow | 0 | 1 | -0 | -0 | 1 | 5 | -3 | -1 | 4 |
| Free cash flow | 0 | 1 | -14 | 5 | 4 | -11 | 4 | -8 | 19 |
| CFO / operating profit | -6% | 171% | -200% | 138% | 100% | -167% | 118% | -55% | 629% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Medico Intercontinental Ltd operating ratios
| Per year | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 28% | 36% | 25% | 25% | 17% | 12% | 13% | -2% |
| Debtor days | — | 237 | 101 | 94 | 84 | 157 | 119 | 124 | 119 |
| Inventory days | 0 | 26 | 46 | 58 | 47 | 52 | 69 | 42 | 87 |
| Days payable | — | 201 | 74 | 67 | 50 | 67 | 30 | 36 | 82 |
| Cash conversion cycle | — | 62 | 74 | 85 | 81 | 143 | 158 | 130 | 124 |
| Working capital days | — | 78 | 74 | 68 | 66 | 132 | 134 | 154 | 76 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Medico Intercontinental Ltd shareholding pattern
Promoters held 58.51% at Jun 2026, up from 55.17% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 55.08% | 55.17% | 55.17% | 55.17% | 55.17% | 57.15% | 57.15% | 58.51% |
| Public | 44.94% | 44.83% | 44.82% | 44.83% | 44.84% | 42.86% | 42.86% | 41.48% |
| No. of shareholders | 3,577 | 3,759 | 3,731 | 3,696 | 3,625 | 3,575 | 3,499 | 3,489 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Medico Intercontinental Ltd corporate filings
- Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018Company Updatelow impact
- Corporate Voting Results Confirm Requisite Majority for Key Resolutions at 42nd AGM of Medico Intercontinental LimitedAGM/EGMmedium impact
Cruxal's analysis: Medico Intercontinental Limited has successfully obtained the necessary majority for all…
Read the full analysis - Medico Intercontinental Limited holds 42nd AGM; no new financial disclosures or strategic announcements reportedAGM/EGMlow impact
Cruxal's analysis: Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
- Medico Intercontinental Ltd: Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: Medico Intercontinental Ltd has published its financial results in newspapers as per…
Read the full analysis - Medico Intercontinental Limited Announces 42nd AGM and Seeks Shareholder Approval for Material Related Party TransactionsAGM/EGMhigh impact
Cruxal's analysis: Medico Intercontinental Limited has scheduled its 42nd Annual General Meeting for…
Read the full analysis - Medico Intercontinental Ltd files Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Medico Intercontinental Ltd has submitted its Annual Report in compliance with Regulation…
Read the full analysis - Medico Intercontinental Ltd announces Book Closure and Annual General MeetingCorp. Actionlow impact
Cruxal's analysis: Medico Intercontinental Ltd has issued an intimation regarding the closure of its…
Read the full analysis - Medico Intercontinental Ltd: Newspaper Publication of Financial ResultsCompany Updatelow impact
Cruxal's analysis: Medico Intercontinental Ltd has fulfilled its regulatory obligation under Regulation 30…
Read the full analysis - Medico Intercontinental Ltd. Reports Q1 FY27 Standalone Profit Growth Amidst Consolidated LossesBoard Meetingmedium impact
Cruxal's analysis: Medico Intercontinental Ltd. reported standalone revenue of 14.33 crore and a net profit…
Read the full analysis - Medico Intercontinental Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Medico Intercontinental Limited has formally intimated the BSE regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.